|
1
|
Goswami BK, Rajashri C, Subrata B, Ankita
D, Banerjee GS and Sudipta C: Clinico-hematological parameters of
sickle hemoglobin hemoglobinopathies and its correlation with
ethnicity: A study from northern districts of west Bengal. Biomed
Biotechnol Res J. 4:342–345. 2020.
|
|
2
|
Sharma HD, Devi KB, Kumar P, Singh KB,
Princy JD and Boini R: Pattern of hemoglobinopathies and
thalassemia in Manipur, India. Int J Adv Med. 7:474–477. 2020.
|
|
3
|
Al-Taie A, Ammar U, Kayas H and Tahir H:
Thalassemia disorders: A scoping insight toward management and
patient care prospects. J Preventive Diagnostic Treatment
Strategies Med. 3:145–153. 2024.
|
|
4
|
Gupta A, Gangane N, Dhanvij M, Davile M,
Mundle S and Yadav A: Prenatal invasive diagnostic testing for
hemoglobinopathies: A retrospective cohort study at a tertiary care
public hospital in central India. Int J Reproduction Contraception
Obstetr Gynecol. 14:1851–1855. 2025.
|
|
5
|
Ali S, Mumtaz S, Shakir HA, Khan M, Tahir
HM, Mumtaz S, Mughal TA, Hassan A, Kazmi SAR, Sadia , et al:
Current status of beta-thalassemia and its treatment strategies.
Mol Genet Genomic Med. 9(e1788)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kountouris P, Stephanou C, Archer N,
Bonifazi F, Giannuzzi V, Kuo K, Maggio A, Makani J, Pereira MDM,
Michailidou K, et al: P1481: The international hemoglobinopathy
research network (INHERENT): An international initiative to study
the role of genetic modifiers in hemoglobinopathies. HemaSphere.
6:1363–1364. 2022.
|
|
7
|
Ibrahim HF, Mahdi AM, Salih A, Al Fatlawi,
Mohammed SN, Harrewee AO and Hameed RM: An immunological and
molecular study to investigate the genes (β-globin and HBA1F) in
patients with thalassemia in Najaf governorate. J Preventive
Diagnostic Treatment Strategies Med. 3:85–91. 2024.
|
|
8
|
Kundu S and Jana A: Consanguineous
marriage and associated diseases among their children and
grandchildren in India: Evidence from large-scale data. J Biosoc
Sci. 56:796–808. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zahraa Qasim Mohammed A H A S A, Hamad AS,
Mohan SJ, Mutashar HM and Abdulabbas HT: The prevalence of people
about to get married who carry genes for hereditary blood diseases
and their relationship to the occurrence of the disease. Curr Clin
Med Edu. 2:29–43. 2024.
|
|
10
|
Singh P, Shaikh S, Parmar S and Gupta R:
Current status of beta-Thalassemic burden in India. Hemoglobin.
47:181–190. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Putchen DD, Kulkarni S, Nanjundarao SS,
Bhat DG, Venkatachala PK and Prasad SR: Retrospective study on the
distribution of hemoglobinopathies in Karnataka-A laboratory
experience. Indian J Pathol Microbiol. 67:585–591. 2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Menezes JF, Carvalho MOS, Rocha LC, Dos
Santos FM, Adorno EV, de Souza CC, Santiago RP, da Guarda CC, de
Oliveira RM, Figueiredo CVB, et al: Role of paraoxonase 1 activity
and PON1 gene polymorphisms in sickle cell disease. Sci Rep.
13(7215)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Diels S, Cuypers B, Tvarijonaviciute A,
Derudas B, Van Dijck E, Verrijken A, Van Gaal LF, Laukens K,
Lefebvre P, Ceron JJ, et al: A targeted multi-omics approach
reveals paraoxonase-1 as a determinant of obesity-associated fatty
liver disease. Clin Epigenetics. 13(158)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yigitturk O, Turgay F, Kizildag S, Ozsoylu
D and Balci GA: Do PON1-Q192R and PON1-L55M polymorphisms modify
the effects of hypoxic training on paraoxonase and arylesterase
activity? J Sport Health Sci. 12:266–274. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kumar R, Saini V, Kaur C, Isser H, Tyagi N
and Sahoo S: Association between PON1 rs662 gene polymorphism and
serum paraoxonase1 level in coronary artery disease patients in
Northern India. Egypt J Med Hum Genet: 22, 2021.
|
|
16
|
Khalil A, Fulop T and Berrougui H: Role of
Paraoxonase1 in the regulation of High-density lipoprotein
functionality and in cardiovascular protection. Antioxid Redox
Signal. 34:191–200. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ferreira CR, Carpenter TO and Braddock DT:
ENPP1 in blood and bone: Skeletal and soft tissue diseases induced
by ENPP1 deficiency. Annu Rev Pathol. 19:507–540. 2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li C and Liu L: Correlation between ENPP1
Gene rs1044498 polymorphism with the risk of type 2 diabetes
mellitus: A Meta-analysis. Tohoku J Exp Med. 266:19–28.
2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mtatiro SN, Makani J, Mmbando B, Thein SL,
Menzel S and Cox SE: Genetic variants at HbF-modifier loci moderate
anemia and leukocytosis in sickle cell disease in Tanzania. Am J
Hematol. 90:E1–E4. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jawarkar A and Bhatia V: A study of HPLC
patterns in patients of sickle cell anemia with analysis of red
cell parameters. Int J Res Med Scie. 6:2390–2395. 2018.
|
|
21
|
Singh V, Biswas AK, Baranwal AK, Asthana B
and Dahiya T: Prevalence of hemoglobinopathies using
high-performance liquid chromatography as diagnostic tool in anemic
patients of tertiary care center of Western India. Asian J Transfus
Sci. 18:257–263. 2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pathak V, Sharma I, Agrawal A and Mund P:
Prevalence of hemoglobinopathies detected by high performance
liquid chromatography in tertiary care centre, Kota, Rajasthan. Int
J Adv Med. 11:476–479. 2024.
|
|
23
|
Belisario AR, Sales RR, Toledo NE,
Velloso-Rodrigues C, Silva CM and Viana MB: Association between
ENPP1 K173Q and stroke in a newborn cohort of 395 Brazilian
children with sickle cell anemia. Blood. 126:1259–1260.
2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Silva M, Vargas S, Coelho A, Ferreira E,
Mendonca J, Vieira L, Maia R, Dias A, Ferreira T, Morais A, et al:
Biomarkers and genetic modulators of cerebral vasculopathy in
sub-Saharan ancestry children with sickle cell anemia. Blood Cells
Mol Dis. 83(102436)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Silva M and Faustino P: From stress to
Sick(le) and back Again-Oxidative/antioxidant mechanisms, genetic
modulation, and cerebrovascular disease in children with sickle
cell anemia. Antioxidants (Basel). 12(1977)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou X, Yang N, Xu W, Li X, Spiliopoulou A
and Theodoratou E: Associations of genetic factors with vascular
diabetes complications: An umbrella review. J Glob Health.
15(04081)2025.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Osunkwo I, Manwani D and Kanter J: Current
and novel therapies for the prevention of vaso-occlusive crisis in
sickle cell disease. Ther Adv Hematol.
11(2040620720955000)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Aich A, Lamarre Y, Sacomani DP, Kashima S,
Covas DT and de la Torre LG: Microfluidics in sickle cell disease
research: State of the art and a perspective beyond the flow
problem. Front Mol Biosci. 7(558982)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zedde M, Quaresima M, Capodanno I,
Grisendi I, Assenza F, Napoli M, Moratti C, Pavone C, Bonacini L,
Di Cecco G, et al: Neurovascular manifestations of sickle cell
disease. Hemato. 5:277–320. 2024.
|
|
30
|
Namipashaki A, Razaghi-Moghadam Z and
Ansari-Pour N: . The essentiality of reporting Hardy-Weinberg
equilibrium calculations in population-based genetic association
studies. Cell J. 17:187–192. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li B and Leal SM: Deviations from
Hardy-Weinberg equilibrium in parental and unaffected sibling
genotype data. Hum Hered. 67:104–115. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Salanti G, Amountza G, Ntzani EE and
Ioannidis JP: Hardy-Weinberg equilibrium in genetic association
studies: An empirical evaluation of reporting, deviations, and
power. Eur J Hum Genet. 13:840–848. 2005.PubMed/NCBI View Article : Google Scholar
|
